BRIEF published on 07/22/2024 at 12:05, 1 year 4 months ago Lupus Alpha Asset Management AG Discloses Position in Crest Nicholson Holdings Plc Takeover Code Stock Sale Investment Disclosure Crest Nicholson Lupus Alpha
PRESS RELEASE published on 07/22/2024 at 12:00, 1 year 4 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses a 3.9409% stake in Crest Nicholson Holdings Plc. Details per UK Takeover Code Rule 8.3 on 22-Jul-2024 Disclosure Takeover Code Stake Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
BRIEF published on 07/19/2024 at 15:35, 1 year 4 months ago Lupus Alpha Asset Management AG Discloses Interest in Crest Nicholson Holdings Plc Asset Management Takeover Code Securities Disclosure Crest Nicholson Lupus Alpha
PRESS RELEASE published on 07/19/2024 at 15:30, 1 year 4 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses a 3.9615% ownership position in Crest Nicholson Holdings Plc. Details of the disclosure per Rule 8.3 of the Takeover Code Disclosure Rule 8.3 Ownership Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
BRIEF published on 07/15/2024 at 12:35, 1 year 4 months ago Lupus Alpha Asset Management AG: Disclosure on Crest Nicholson Holdings Plc Disclosure Takeover Code Crest Nicholson Holdings Lupus Alpha Asset Management Public Position
PRESS RELEASE published on 07/15/2024 at 12:30, 1 year 4 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses 3.93% stake in Crest Nicholson Holdings Plc. Public position disclosure under Rule 8.3 of the Takeover Code Disclosure Rule 8.3 Takeover Code Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
BRIEF published on 07/08/2024 at 12:05, 1 year 4 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Form 8.3 Takeover Code Public Disclosure Crest Nicholson Holdings Lupus Alpha Asset Management
PRESS RELEASE published on 07/08/2024 at 12:00, 1 year 4 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses 3.8942% stake in Crest Nicholson Holdings Plc. Form 8.3 announcement on 05.07.2024 Form 8.3 Disclosure Stake Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
BRIEF published on 07/05/2024 at 13:05, 1 year 4 months ago Form 8.3 Submission by Lupus Alpha Asset Management AG Regarding Crest Nicholson Holdings Plc Securities Form 8.3 Disclosure Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
PRESS RELEASE published on 07/05/2024 at 13:00, 1 year 4 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses a 3.8157% stake in Crest Nicholson Holdings Plc per Form 8.3, dated 05-Jul-2024 Form 8.3 Disclosure Stake Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
Published on 12/05/2025 at 02:35, 5 hours ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 35 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 30 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 35 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 35 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 5 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 44 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 10 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 20 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 35 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 50 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 51 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
